Guideline-directed Medical Therapy in Patients with Heart Failure – from Diagnosis to Therapy and Beyond

Released On
September 20, 2019

Expires On
September 20, 2020

Media Type

Completion Time
60 minutes

Cardiology, Primary Care

Heart Failure

Scroll to the Bottom of this Information to Begin this Course

This activity is jointly provided by Postgraduate Institute for Medicine and PlatformQ Health Education, LLC.


Supported by an educational grant from Novartis.

Credit Available

  • Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)

All other healthcare professionals completing this course will be issued a statement of participation.

Target Audience

This activity is intended for cardiologists, interventional cardiologists, primary care physicians, internists, advanced practitioners (nurse practitioners, physician assistants), pharmacists, and other health care providers who care for patients with heart failure.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Incorporate the recent updates from the 2017 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure into clinical practice
  • Recognize the multiple barriers that hinder the application of guideline-directed medical therapy in patients with HF
  • Provide optimal therapeutic dosing of recently introduced options to enhance health outcomes in patients with HF
  • Incorporate the recent updates from the 2017 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure into clinical practice
  • Identify risk factors for significant morbidity and mortality that are associated with HF, particularly post hospitalization


James L. Januzzi, Jr., MD, FACC, FESC

Physician, Cardiology Division
Director, Dennis and Marilyn Barry Fellowship in Cardiology Research
Massachusetts General Hospital
Hutter Family Professor of Medicine in the Field of Cardiology
Harvard Medical School
Cardiometabolic Faculty
Baim Institute for Clinical Research

Gregg C. Fonarow, MD, FACC, FAHA, FHFSA

Eliot Corday Professor of Cardiovascular Medicine and Science
Director, Ahmanson-UCLA Cardiomyopathy Center
Co-Chief, UCLA Division of Cardiology
Co-Director, UCLA Preventative Cardiology Program
David Geffen School of Medicine at UCLA

Nasrien E. Ibrahim, MD

Assistant Professor of Medicine
Harvard Medical School
Associate Director, Resynchronization & Advanced Cardiac Therapeutics Program
Massachusetts General Hospital

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and PlatformQ Health Education, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statement

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

James L. Januzzi, Jr., MD, FACC, FESC

  • Consulting Fees: Novartis, Janssen, Boehringer-Ingelheim, Roche
  • Contracted Research: Novartis, Roche

Gregg C. Fonarow, MD, FACC, FAHA, FHFSA

  • Consulting Fees: Novartis, Medtronic, Amgen, Janssen, Abbott
  • Fees for Non-CME/CE Services Received Directly from a Commercial Interest or their Agents: Novartis
  • Contracted Research: NIH

Nasrien E. Ibrahim, MD

  • None

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Joe Chebli, none.

The PIM planners and managers have nothing to disclose.

The following PlatformQ Health Education, LLC planner, Elizabeth del Nido, hereby states that she or her spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Disclosure of Unapproved/Off Label Use (if applicable):

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Method of Participation

There are no fees to participate in this activity. To participate in the activity, go to To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, participants must receive a minimum score of 70% on the post-test.

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Contact Information

Accreditation Suppport:
Please contact the Postgraduate Institute for Medicine at

Technical Support:
For any technical issues or issues with your CME Certificate, please contact CardioCareLive at 877-394-1306 or at

PlatformQ Health Privacy Policy:

By clicking “Start Activity” you are agreeing to PlatformQ Health’s privacy policy. PlatformQ Health takes your privacy very seriously. The full Privacy Policy found here describes (i) the types of information we collect from you when you visit our Site; (ii) how we use the information we collect; (iii) with whom and why we share it; and (iv) the choices we offer regarding our use of the information. We also describe how to contact us about our privacy practices.

Information we collect is primarily used to communicate with program participants, award CME/CE credits, manage user accounts, recommend relevant programs and perform data analysis to inform educational outcomes.

In plain English, here is what we affirm:

  • You can change your registration profile at any time from our “Profile” page
  • To request any of these changes without logging in, please call us at 1 (877) 394-1306 or email us at
  • You can end your association with PlatformQ Health at any time
  • PlatformQ Health does not spam, nor we do we rent or sell our email list in whole or in part. Any program-related data sharing is for engagement verification and opt-in based further education
  • EU citizens can request a complete record of their account and/or request to have their personal data expunged by contacting with the subject line “Data Request”

You acknowledge and agree that by beginning this activity, you have affirmatively agreed to this Privacy Policy and consented to receiving electronic messages in conformance with this Privacy Policy. Please read the full privacy policy located at: